Last reviewed · How we verify
Normal nicotine content cigar
Normal nicotine content cigar is a Small molecule drug developed by Ohio State University Comprehensive Cancer Center. It is currently FDA-approved for Research tool for studying nicotine exposure and smoking-related cancer risk. Also known as: FLC.
A normal-nicotine content cigar serves as a research control or comparative product to study the effects of nicotine exposure and smoking behavior.
A normal-nicotine cigar product designed as a research or control comparator to study nicotine exposure and smoking-related health outcomes. Used for Research/control product for smoking and cancer studies.
At a glance
| Generic name | Normal nicotine content cigar |
|---|---|
| Also known as | FLC |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Mechanism of action
This product appears to be a standardized research tool used by Ohio State University Comprehensive Cancer Center, likely for comparative studies examining nicotine delivery, smoking patterns, or cancer risk assessment. It functions as a baseline or control product rather than a therapeutic agent with a defined pharmacological mechanism.
Approved indications
- Research tool for studying nicotine exposure and smoking-related cancer risk
Common side effects
- Nicotine dependence
- Respiratory irritation
- Cardiovascular effects
Key clinical trials
- Addiction Potential of Very Low Nicotine Filtered Little Cigars (PHASE4)
- Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Normal nicotine content cigar CI brief — competitive landscape report
- Normal nicotine content cigar updates RSS · CI watch RSS
- Ohio State University Comprehensive Cancer Center portfolio CI
Frequently asked questions about Normal nicotine content cigar
What is Normal nicotine content cigar?
How does Normal nicotine content cigar work?
What is Normal nicotine content cigar used for?
Who makes Normal nicotine content cigar?
Is Normal nicotine content cigar also known as anything else?
What development phase is Normal nicotine content cigar in?
What are the side effects of Normal nicotine content cigar?
Related
- Manufacturer: Ohio State University Comprehensive Cancer Center — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Research tool for studying nicotine exposure and smoking-related cancer risk
- Also known as: FLC
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing